Aarti Drugs Updates Authorized Key Management Personnel for Materiality Disclosures
Aarti Drugs Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 12:38 am
Aarti Drugs Updates Authorized Key Management Personnel for Materiality Disclosures Pursuant to Regulation 30(5) of SEBI LODR Regulations and following Directorate and Management changes, Aarti Drugs Limited updated its authorized personnel effective 1st Oct'26. Managing Director Adhish P. Patil and Joint Managing Director Harshit M. Savla are authorized to determine event materiality and make stock exchange disclosures. Additionally, Company Secretary and Compliance Officer Rushikesh V. Deole is authorized to execute disclosures to stock exchanges.
Original exchange filing (PDF)
More announcements from Aarti Drugs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Transcript of Q2&H1 FY27 Earning Conference call 路 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations, 2015 路 06 Nov 2026
- Audio recording for conference call for Analyst and Investors 路 05 Nov 2026
- Investor Presentation for Q2 FY27 路 04 Nov 2026
- Press release on Financial results for Quarter and Half year ended September 2026 路 04 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Aarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
